Statement, Policies & Safety Precautions RE: Coronavirus (COVID-19)
As of March 10, 2020
The health and safety of our attendees, and stakeholders are of the utmost importance to us. We are continuing to plan for the IP Counsels Committee Conference (IPCC), while closely monitoring new measures and directives around mitigation of the novel coronavirus (COVID-19) outbreak. Our approach is both vigilant and cautious as we face the many unknown variables before us. Our goal remains to provide the best business approach and solution for our biotech community.
As the COVID-19 situation continues to evolve between now and June, we will provide you with regular planning updates on this webpage and through email communications as we work with our vendors, partners, local representatives, government agencies, and health officials to produce the most important event in our industry
Everyone is encouraged to follow the most conservative guidelines available from leading global and local health authorities (such as the CDC and WHO), which include frequent hand washing, covering coughs and sneezes, and staying home when ill.
Learn more about the biopharmaceutical industry’s response to COVID-19.
Recommended Resources:
